We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
NOVVU | Nova Vision Acquisition Corporation | 41.00 | 27.66 | 207.35% | 17,397 |
NOVV | Nova Vision Acquisition Corporation | 37.0001 | 24.67 | 200.08% | 202,745 |
SMX | SMX Security Matters Public Company | 5.85 | 3.40 | 138.78% | 49,723,185 |
OMIC | Singular Genomics Systems Inc | 12.38 | 6.73 | 119.12% | 2,718,151 |
TIL | Instill Bio Inc | 84.75 | 38.29 | 82.41% | 3,760,872 |
TNON | Tenon Medical Inc | 7.4597 | 3.06 | 69.54% | 23,486,293 |
IMRX | Immuneering Corporation | 2.02 | 0.59 | 41.26% | 131,848,433 |
AEHL | Antelope Enterprise Holdings Ltd | 1.07 | 0.28 | 35.44% | 1,144,484 |
MRNO | Murano Global Investments PLC | 9.50 | 2.21 | 30.32% | 87,656 |
NNE | Nano Nuclear Energy Inc | 15.22 | 3.52 | 30.09% | 4,499,982 |
JBDI | JBDI Holdings Ltd | 26.48 | 5.85 | 28.36% | 498,323 |
- Encouraging signs of anti-tumor activity including objective responses observed in patients with SMARCA4-mutated non-small cell lung cancer (NSCLC) and esophageal cancer in early PRT3789 monotherapy dose escalation - At doses studied to date, PRT3789 was generally well-tolerated with no dose-limiting toxicities or study drug-related serious adverse events - Company to host investor conference call and webcast on Friday, September 13, 2024 at 12:00 PM EST ...
Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today announced the Company will share new data from Module 1 of its ongoing Phase 1/2 TRESR clinical trial during an oral presentation on September 14 at the European Society for Medical Oncology Congress (ESMO), held in Barcelona, Spain.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
ELTP | Elite Pharmaceuticals Inc | 56 | |
FNMA | Fannie Mae-No Politics | 43 | |
HIRU | Hiru Corporation | 16 | |
4 | BIEL | Bioelectronics Corp | 34 |
5 | VPLM | Voip Pal Com Inc | 18 |
6 | NSAV | NSAV Holding Inc | 20 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 58,523.74 | -651.92 | -1.10% | 1.15T | 1,796,021,504 |
ETH | Ethereum | 2,271.33 | -49.77 | -2.14% | 275.45B | 990,636,411 |
USDT | Tether USD | 0.99993 | 0.00001 | 0.00% | 97.84B | 76,450,161 |
BNB | Binance Coin | 548.22 | -5.72 | -1.03% | 87.02B | 158,557,864 |
SOL | Solana | 130.03 | -1.51 | -1.15% | 57.67B | 449,835,705 |
XRP | Ripple | 0.5637 | -0.0077 | -1.35% | 30.95B | 149,428,291 |
USDC | USD Coin | 0.9998 | -0.0001 | -0.01% | 28.07B | 323,867,407 |
STETH | stETH | 2,269.02 | -51.84 | -2.23% | 22.45B | 3,483,177 |
TONCOIN | Wrapped TON Coin | 5.47 | -0.061639 | -1.11% | 19.14B | 54,544,241 |
DOGE | Dogecoin | 0.10123 | -0.00174 | -1.69% | 14.6B | 102,358,029 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions